Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 11948229)

Published in Jpn J Clin Oncol on February 01, 2002

Authors

Katsuki Ito1, Kenji Hibi, Hideyuki Ando, Kazuhiko Hidemura, Taiji Yamazaki, Seiji Akiyama, Akimasa Nakao

Author Affiliations

1: Department of Surgery II, School of Medicine, Nagoya University, Nagoya, Japan. katsuki@tsuru.med.nagoya-u.ac.jp

Articles by these authors

Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery (2013) 2.43

Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas (2004) 2.30

Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a critical reappraisal from the viewpoint of lymph node retrieval. J Am Coll Surg (2004) 2.18

Myocardial velocity gradient as a noninvasively determined index of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (2003) 2.05

Middle pancreatectomy: safety and long-term results. Surgery (2009) 1.69

Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis. Hepatology (2006) 1.61

Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. J Hepatol (2004) 1.55

Long term parathyroid function following total parathyroidectomy with autotransplantation in adult patients with MEN2A. Endocr J (2009) 1.54

Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas (2011) 1.52

Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. J Gastroenterol (2004) 1.52

DeltaNp63 induces beta-catenin nuclear accumulation and signaling. Cancer Cell (2002) 1.51

Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease. J Gastroenterol (2005) 1.50

MACC 1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res (2011) 1.48

Clinical significance of regulatory T-cell-related gene expression in peripheral blood after renal transplantation. Transplantation (2011) 1.47

Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin Cancer Res (2002) 1.46

Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat (2002) 1.45

MACC 1 as a marker for peritoneal-disseminated gastric carcinoma. Anticancer Res (2010) 1.42

Laparoscopic surgery for gastric cancer: a collective review with meta-analysis of randomized trials. J Am Coll Surg (2010) 1.42

Enzyme-linked immunosorbent assay for human leukocyte antigen antibody detection and urine protein test recommended for follow-up monitoring after renal transplantation. Transplantation (2008) 1.40

Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22. World J Surg (2011) 1.33

Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Pancreas (2012) 1.31

Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Ann Surg Oncol (2009) 1.27

Longterm outcomes of early-stage gastric carcinoma patients treated with laparoscopy-assisted surgery. J Am Coll Surg (2007) 1.26

Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis. Int J Oncol (2009) 1.25

PGP9.5 as a marker for invasive colorectal cancer. Clin Cancer Res (2002) 1.21

Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma: a review of 43 cases. J Am Coll Surg (2003) 1.21

MACC1 as a marker for advanced colorectal carcinoma. Anticancer Res (2010) 1.21

Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma. Mol Carcinog (2011) 1.20

Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann Surg Oncol (2008) 1.19

Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo. Oncogene (2002) 1.19

Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis. Clin Cancer Res (2003) 1.15

Vimentin methylation as a marker for advanced colorectal carcinoma. Anticancer Res (2009) 1.13

The potential of oncolytic virus therapy for pancreatic cancer. Cancer Gene Ther (2005) 1.13

A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703). Gastric Cancer (2010) 1.13

Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery? Pancreas (2009) 1.11

Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res (2002) 1.09

Characterization of in vitro gutlike organ formed from mouse embryonic stem cells. Am J Physiol Cell Physiol (2004) 1.09

Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis. J Hepatol (2002) 1.09

Negative pressure external drainage of the pancreatic duct in pancreaticoduodenectomy. Hepatogastroenterology (2010) 1.09

Preservation of the pyloric ring has little value in surgery for pancreatic head cancer: a comparative study comparing three surgical procedures. Ann Surg Oncol (2011) 1.08

Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation? Xenotransplantation (2004) 1.06

Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters. J Surg Oncol (2008) 1.06

Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Liver Int (2005) 1.06

Para-aortic lymph node metastasis in carcinoma of the head of the pancreas. Surgery (2005) 1.06

Amylase concentration of the drainage fluid as a risk factor for intra-abdominal abscess following gastrectomy for gastric cancer. World J Surg (2010) 1.04

Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2013) 1.04

Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol (2003) 1.01

Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival. Pancreas (2009) 1.01

Simultaneous Doppler measurement of portal venous peak velocity, hepatic arterial peak velocity, and splenic arterial pulsatility index for assessment of hepatic circulation. Hepatogastroenterology (2002) 1.01

Intrahepatic venous anastomosis formation of the right liver in living donor liver transplantation: evaluations by Doppler ultrasonography and pulse-inversion ultrasonography with Levovist. Surgery (2005) 0.99

High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer. Breast Cancer (2006) 0.99

Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen. Gastric Cancer (2005) 0.99

Metachronous double cancer of the gallbladder and common bile duct. J Hepatobiliary Pancreat Surg (2004) 0.99

Classification of the celiac axis stenosis owing to median arcuate ligament compression, based on severity of the stenosis with subsequent proposals for management during pancreatoduodenectomy. Surgery (2011) 0.99

Methylation of HACE1 in gastric carcinoma. Anticancer Res (2009) 0.99

Construct validity of the LapVR virtual-reality surgical simulator. Surg Endosc (2010) 0.99

Pattern of lymph node metastasis spread in pancreatic cancer. Pancreas (2011) 0.99

Dibenzoborole-containing pi-electron systems: remarkable fluorescence change based on the "on/off" control of the p(pi)-pi* conjugation. J Am Chem Soc (2002) 0.98

Hyperlactemia can predict the prognosis of liver resection. Shock (2007) 0.98

TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clin Exp Metastasis (2004) 0.97

Prognostic significance of postoperative complications after hepatectomy for hepatocellular carcinoma. J Surg Oncol (2011) 0.97

Pilot study of oncolytic viral therapy using mutant herpes simplex virus (HF10) against recurrent metastatic breast cancer. Ann Surg Oncol (2006) 0.97

Decreased expression and aberrant hypermethylation of the SFRP genes in human gastric cancer. Hepatogastroenterology (2011) 0.97

Multicenter phase II study of FOLFOX for metastatic colorectal cancer (mCRC) in Japan; SWIFT-1 and 2 study. Hepatogastroenterology (2009) 0.97

Nutritional recovery after open and laparoscopic gastrectomies. Gastric Cancer (2011) 0.96

Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler. Cancer Lett (2002) 0.96

Differentiation of acinar cells into acinoductular cells in regenerating rat pancreas. Pancreatology (2003) 0.96

Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a phase II study following the learning curve. J Surg Oncol (2005) 0.96

Methylation pattern of HLTF gene in digestive tract cancers. Int J Cancer (2003) 0.96

Obesity and outcome of distal gastrectomy with D2 lymphadenectomy for carcinoma. Hepatogastroenterology (2004) 0.95

Plasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer. Cancer Sci (2006) 0.95

Chemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Cancer Sci (2003) 0.95

Transhepatic portal venous angioplasty with stenting for bleeding jejunal varices. Hepatogastroenterology (2005) 0.94

Suppressor of cytokine signaling 4 detected as a novel gastric cancer suppressor gene using double combination array analysis. World J Surg (2012) 0.94

Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation. Xenotransplantation (2010) 0.93

Aggressive surgery for borderline resectable pancreatic cancer: evaluation of National Comprehensive Cancer Network guidelines. Pancreas (2013) 0.93

Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array. Cancer Lett (2009) 0.93